Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HeraMED Ltd. ( (AU:HMD) ) has provided an update.
HeraMED Ltd has requested and been granted a trading halt on its ordinary shares on the Australian Securities Exchange, effective 22 January 2026, while it prepares a market announcement regarding a material proposed capital raising. The halt, which is intended to help the company manage its continuous disclosure obligations and maintain an orderly market in its securities, will remain in place until the earlier of the start of trading on 27 January 2026 or the release of the capital-raising announcement, signaling a potentially significant funding move that could impact existing shareholders and the company’s capital structure.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Ltd (ASX:HMD) is an Australian-listed company whose shares trade on the Australian Securities Exchange. The announcement relates specifically to its ordinary shares and their trading status on the ASX.
Average Trading Volume: 1,060,494
Technical Sentiment Signal: Buy
Current Market Cap: A$46.02M
See more insights into HMD stock on TipRanks’ Stock Analysis page.